RelayPro Thoracic Stent-Graft System
Bolton Medical, Inc. · Decision date Jul 22, 2025
What did the FDA approve?
FDA records P200045/S016 as a supplement to PMA P200045, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jul 22, 2025.
FDA approval order statement
Approval for extension of shelf-life to 3-years
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Jul 22, 2025
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P200045/S016
- Regulatory pathway
- PMA supplement
- Applicant
- Bolton Medical, Inc.
- Product code
- MIH
- Decision code
- APPR
- Decision date
- Jul 22, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.
- Applicant
- Bolton Medical, Inc.
- Product code
- MIH
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P200045. Subsequent supplements may change the device or its indications.
FDA decision timeline
P200045 · Original PMA
RelayPro Thoracic Stent-Graft System
P200045/S016 received
Application receipt date recorded by FDA.
P200045/S016 · FDA decision
Real-Time Process
P200045/S020 · Related supplement
RelayPro Thoracic Stent-Graft System
P200045/S018 · Related supplement
RelayPro Thoracic Stent-Graft System
P200045/S022 · Related supplement
RelayPro Thoracic Stent-Graft System
P200045/S017 · Related supplement
RelayPro Thoracic Stent-Graft System
P200045/S024 · Related supplement
RelayPro Thoracic Stent-Graft System
P200045/S025 · Related supplement
RelayPro Thoracic Stent-Graft Delivery System
Timeline entries are records held by MedtechLedger for P200045. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200045
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bolton Medical, Inc. | PMA approval | Aug 5, 2021 | FDA | |
RelayProP200045/S019 | Bolton Medical, Inc. | PMA supplement | Sep 3, 2025 | FDA |
RelayPro Thoracic Stent-Graft SystemP200045/S020 | Bolton Medical, Inc. | PMA supplement | Sep 10, 2025 | FDA |
RelayPro Thoracic Stent-Graft SystemP200045/S018 | Bolton Medical, Inc. | PMA supplement | Oct 7, 2025 | FDA |
RelayPro Thoracic Stent-Graft SystemP200045/S022 | Bolton Medical, Inc. | PMA supplement | Feb 19, 2026 | FDA |
RelayPro Thoracic Stent-Graft SystemP200045/S017 | Bolton Medical, Inc. | PMA supplement | Apr 13, 2026 | FDA |
RelayPro Thoracic Stent-Graft SystemP200045/S024 | Bolton Medical, Inc. | PMA supplement | Jun 18, 2026 | FDA |
RelayPro Thoracic Stent-Graft Delivery SystemP200045/S025 | Bolton Medical, Inc. | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code MIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook, Inc. | PMA supplement | Sep 17, 2026 | FDA | |
| Cook, Inc. | PMA supplement | Aug 4, 2026 | FDA | |
| Cook Medical Incorporated | PMA supplement | Aug 4, 2026 | FDA | |
| William Cook Europe Aps | PMA supplement | Aug 4, 2026 | FDA | |
GORE EXCLUDER Conformable AAA EndoprosthesisP200030/S026 | W. L. Gore and Associates, Inc. | PMA supplement | Jul 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bolton Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 799 International Pkwy., Sunrise, FL, 33325
Sources and methodology
- Original FDA record: P200045/S016
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




